BACKGROUND: Recent randomized trials have demonstrated that for patients with severe tricuspid regurgitation (TR), transcatheter tricuspid valve interventions (TTVI) improve patients’ symptoms, ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...
Oh yes, and there are also the usual slots – three, in this case – for optional vials of glow-in-the-dark tritium. Assuming the WingSpan multitool reaches production, a pledge of US$139 will get you ...
is a fluid control device. It uses a 1/4 turn rotation to control the flow of media in various processes. Knowing the materials and functions of the parts is vital. It helps to choose the right valve ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR), announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results